Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS)
NCT ID: NCT05866484
Last Updated: 2024-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
280 participants
OBSERVATIONAL
2023-05-10
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The best way for sperm selection and processing in assisted reproductive technologies (ART) should be noninvasive and cost-effective. It should also make it possible to identify high-quality spermatozoa and produce more favorable results in terms of pregnancy and live birth rates.7 Meanwhile, the microfluidic sperm separation technology is a less expensive and less invasive alternative. This method allows for the selection of motile sperm that have a normal morphology, low levels of reactive oxygen species (ROS), and low DFI
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testicular Versus Ejaculated Spermatozoa for IVF/ICSI in Men With High Sperm DNA Damage
NCT02058082
Identifying Candidates for Limited Dissection at Microdissection TESE.
NCT07286279
Comparison of ICSI Outcomes in Cycles Using Testicular and Ejaculate Sperm From Couples With High SDF
NCT04795440
Surgical Sperm Retrieval in Non-obstructive Azoospermic Men: mTESE vs. TESA
NCT03550716
Timing of Oocyte Retrieval and Micro Testicular Sperm Extraction
NCT07268235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TESA-ICSI
Compare ICSI outcomes with high Sperm DNA fragmentation undergoing TESA (testicular sperm extraction)
No interventions assigned to this group
Zymot-ICSI
Compare ICSI outcomes with high Sperm DNA fragmentation using microfluidic sperm separation device (Zymot)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Egg donation cycle
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinique Ovo
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Armand Zini, MD
Role: PRINCIPAL_INVESTIGATOR
Clinique Ovo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Ovo
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3277
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.